Objective To update recommendations for antiretroviral therapy for adult human
immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that
are available. Participants A 17-member international physician panel with antiretroviral
research and HIV patient care experience initially convened by the International AIDS
Society–USA in December 1995. Evidence Available clinical and basic science data
including phase 3 controlled trials; data on clinical, virologic, and immunologic end points; …